Display options
Share it on

Front Physiol. 2018 Feb 22;9:102. doi: 10.3389/fphys.2018.00102. eCollection 2018.

Neferine Protects Endothelial Glycocalyx via Mitochondrial ROS in Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome.

Frontiers in physiology

Xiang-Yong Liu, Hai-Xiao Xu, Jian-Kui Li, Dong Zhang, Xiao-Hong Ma, Li-Na Huang, Jun-Hong Lü, Xiao-Zhi Wang

Affiliations

  1. Department of Cell Biology, Binzhou Medical University, Yantai, China.
  2. Department of Respirator Medicine and Intensive Care Unit, Affiliated Hospital of Binzhou Medical University, Binzhou, China.
  3. Division of Physical Biology and CAS Key Laboratory of Interfacial Physics and Technology, Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai, China.

PMID: 29520236 PMCID: PMC5826949 DOI: 10.3389/fphys.2018.00102

Abstract

Damage to the endothelial glycocalyx is a critical factor in increased pulmonary vascular permeability, which is the basic pathological feature of acute respiratory distress syndrome (ARDS). Neferine (Nef), a bisbenzylisoquinoline alkaloid isolated from green seed embryos of

Keywords: acute respiratory distress syndrome; endothelial glycocalyx; lipopolysaccharide; mitochondrial ROS; neferine

References

  1. Scand J Trauma Resusc Emerg Med. 2016 Apr 12;24:48 - PubMed
  2. Crit Care. 2015 Jan 28;19:26 - PubMed
  3. J Pathol. 2012 Mar;226(4):562-74 - PubMed
  4. Inflammation. 2015 Aug;38(4):1669-82 - PubMed
  5. Am J Respir Crit Care Med. 2017 Jul 1;196 (1):18-28 - PubMed
  6. Exp Ther Med. 2016 Sep;12(3):1551-1555 - PubMed
  7. Lancet. 2007 May 5;369(9572):1553-64 - PubMed
  8. Biochem Biophys Res Commun. 2016 Sep 16;478(2):669-75 - PubMed
  9. Am J Respir Cell Mol Biol. 2017 Jun;56(6):727-737 - PubMed
  10. Diabetes. 2016 Sep;65(9):2742-53 - PubMed
  11. Cardiovasc Res. 2017 May 1;113(6):671-680 - PubMed
  12. Biofactors. 2016 Jul 8;42(4):407-17 - PubMed
  13. Pflugers Arch. 2007 Jun;454(3):345-59 - PubMed
  14. Am J Physiol Lung Cell Mol Physiol. 2014 Dec 15;307(12):L924-35 - PubMed
  15. Shock. 2013 Sep;40(3):195-202 - PubMed
  16. Can J Physiol Pharmacol. 2011 Apr;89(4):289-94 - PubMed
  17. Am J Physiol Heart Circ Physiol. 2014 Feb;306(3):H363-72 - PubMed
  18. Int J Mol Sci. 2017 Oct 19;18(10 ):null - PubMed
  19. J Cell Biochem. 2017 Sep;118(9):2865-2876 - PubMed
  20. Mediators Inflamm. 2014;2014:694312 - PubMed
  21. PLoS One. 2015 Jan 09;10 (1):e0117133 - PubMed
  22. FASEB J. 2014 Nov;28(11):4686-99 - PubMed
  23. Tissue Barriers. 2013 Jan 1;1(1):null - PubMed
  24. Vascul Pharmacol. 2018 Jan;100:26-33 - PubMed
  25. Free Radic Biol Med. 2012 Apr 15;52(8):1382-402 - PubMed
  26. J Cell Biochem. 2018 Feb;119(2):1441-1452 - PubMed
  27. N Engl J Med. 2000 May 4;342(18):1334-49 - PubMed
  28. Eur J Pharmacol. 2010 Feb 10;627(1-3):304-12 - PubMed
  29. Thromb Res. 2013 Aug;132(2):202-10 - PubMed
  30. J Trauma Acute Care Surg. 2018 Jan;84(1):81-88 - PubMed
  31. Biomed Res Int. 2016;2016:3758278 - PubMed
  32. Front Physiol. 2017 Jul 07;8:466 - PubMed
  33. PLoS One. 2013;8(2):e55852 - PubMed
  34. Life Sci. 2010 Sep 25;87(13-14):420-30 - PubMed
  35. Am J Trop Med Hyg. 2015 Mar;92(3):611-6 - PubMed
  36. J Clin Invest. 2001 Jan;107(1):7-11 - PubMed
  37. Endocrine. 2014 Dec;47(3):764-71 - PubMed
  38. Nat Med. 2012 Aug;18(8):1217-23 - PubMed
  39. Sci Transl Med. 2016 Apr 20;8(335):335ra55 - PubMed
  40. Antioxid Redox Signal. 2014 Sep 1;21(7):1098-118 - PubMed
  41. Eur J Pharmacol. 2012 Feb 29;677(1-3):47-54 - PubMed
  42. Biofactors. 2014 Jan-Feb;40(1):121-31 - PubMed
  43. J Cell Biochem. 2017 Oct;118(10 ):3472-3479 - PubMed
  44. Int Immunopharmacol. 2014 Sep;22(1):133-40 - PubMed
  45. J Pharmacol Exp Ther. 2017 Apr;361(1):115-121 - PubMed

Publication Types